Coronavirus: Pfizer’s Covid vaccine is linked to MORE blood clots than AstraZeneca’s in the UK

Pfizer’s Covid vaccine has been linked to more blood clots than AstraZeneca’s in reports from the UK, statistics show amid Europe’s ‘baffling’ mass revolt against the jab.  Thirteen countries across the continent have now turned their backs on the Oxford University jab in a knee-jerk reaction over unproven blood clot fears.  The European Medicines Agency … Read more

Coronavirus: Pfizer’s Covid vaccine is linked to MORE blood clots than AstraZeneca’s in the UK

Pfizer’s Covid vaccine has been linked to more blood clots than AstraZeneca’s in reports from the UK, statistics show as Europe reels from a ‘baffling’ decision to snub the jab.  Thirteen countries on the continent have now turned their backs on the Oxford University Covid vaccine after regulators said they were investigating links to deadly … Read more

U.S. data for AstraZeneca’s COVID-19 vaccine clinical trial is under review by independent advisors

Long-awaited results from AstraZeneca Plc’s U.S coronavirus vaccine trial are currently being reviewed by independent advisors to determine whether the shot is safe and effective. Dr Francis Collins, director of the National Institutes of Health (NIH), said the drug company and its partner, the University of Oxford, completed enrollment of 30,000 participants earlier this year.  … Read more

AstraZeneca’s Covid jab is NOT linked to blood clots, top scientists say

There is ‘no signal’ that the Oxford and AstraZeneca Covid vaccine is causing blood clots, scientists have said in response to scaremongering from European officials.  At least five EU countries and Thailand have stopped using the jab on members of the public after reports of people developing clots after having it in some nations. But regulators … Read more

AstraZeneca’s Covid jab is NOT linked to blood clots, top scientists say

There is ‘no signal’ that the Oxford and AstraZeneca Covid vaccine is causing blood clots, scientists have said in response to scaremongering from European officials. At least five EU countries and Thailand have stopped using the jab on members of the public after reports of people developing clots after having it in some nations. But … Read more

UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan

The UK could miss out on millions of doses of the coronavirus vaccine if the European Union suspends deliveries to countries outside the bloc. Britain is expecting to receive another 9million doses by mid-February from Oxford/AstraZeneca and Pfizer/BioNTech. But if Eurocrats blockade jab exports across the channel, American drugs company Pfizer – which manufactures vaccines … Read more

UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan

What would happen if the EU forced Pfizer to stop delivering Covid vaccines? UK could miss out on 3.5m doses between now and February and rely totally on AstraZeneca’s plan to hit 2m per week by Monday Eurocrats proposed plans to stop vaccine exports could cut Britain’s supplies  Pfizer – which manufactures doses in Belgium … Read more

Doctor slams FDA for not approving AstraZeneca’s coronavirus vaccine

A doctor has slammed the U.S. Food and Drug Administration (FDA) for not approving AstraZeneca-University of Oxford’s coronavirus vaccine. On Wednesday, Great Britain became the fist country in the world to grant authorization to the COVID-19 jab. The vaccine holds great appeal because it’s inexpensive – costing $3 to $4 per dose – and can … Read more

MARKET REPORT: Astrazeneca’s game-changer jab given rubber stamp

Drugs giant Astrazeneca reached a crucial milestone yesterday after regulators approved its Covid vaccine for use in the UK. The second-largest company on the FTSE 100 has spent months developing the jab with Oxford University. Around 530,000 doses will be available from next week, turbocharging the number of vaccines that can be rolled out in … Read more

Is Astrazeneca’s for bid American rival a deal too far?

It was a moment of maximum peril for Astrazeneca.  The British drugs giant was laid low and attempting a turnaround, but the raiders were at the gate.  Smelling an opportunity, American rival Pfizer swooped with a £69billion takeover bid which bosses hoped would cut costs and shrink its tax bills.  But in the ensuing struggle, … Read more